Bambusa Therapeutics, Inc. (BBTX)

Bambusa Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Bambusa Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Selling, General & Admin	-	5.91	0.86
Research & Development	-	38.1	13.03
Operating Expenses	-	44.01	13.88
Operating Income	-52.62	-44.01	-13.88
Interest Expense (Income)	-2.75	-2.17	-0.13
Other Expense (Income)	-3.74	-2.98	-0.01
Pretax Income	-46.13	-37.1	-13.74
Income Tax	2.58	2.23	-
Net Income	-48.7	-41.09	-13.74
Net Income Common	-48.7	-39.33	-
Net Income Growth	-	-	-

Additional Metrics

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Free Cash Flow	-40.9	-39.8	-4.63
Free Cash Flow Growth	-	-	-
EBITDA	-48.88	-41.03	-13.87
EBIT	-48.88	-41.03	-13.87